Abstract:Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPG) are necessary for normal cartilage development and chondrocyte differentiation. However, recent studies demonstrated that HSPG accelerate dedifferentiation and catabolism in chondrocytes from degenerative cartilage. In this study, we investigated the inhibitory effect of HSPG on chondrocyte differentiation in vitro. Rat articular chondrocytes were cultured at low (0.3 × 10(4) cells/cm(2) ) and high (1.5 × 10(5) cells/cm(2) ) density in the presence … Show more
“…Furthermore, perlecan can also result in a significant increase in elasticity [39], whereas deficiency leads to reduced cellular and ECM stiffness in vivo. In addition to its inhibitory effect on COLII synthesis [40], perlecan knockdown also resulted in a decrease in the PCM component and an increase in the bulk matrix, suggesting that the ability of newly synthesized ECM to incorporate into the matrix was impaired without influencing the components of ECM.…”
Section: Biomechanical Functions Of Perlecan and Related Structure Ch...mentioning
“…Furthermore, perlecan can also result in a significant increase in elasticity [39], whereas deficiency leads to reduced cellular and ECM stiffness in vivo. In addition to its inhibitory effect on COLII synthesis [40], perlecan knockdown also resulted in a decrease in the PCM component and an increase in the bulk matrix, suggesting that the ability of newly synthesized ECM to incorporate into the matrix was impaired without influencing the components of ECM.…”
Section: Biomechanical Functions Of Perlecan and Related Structure Ch...mentioning
“…Basement membranes are structures which finely tune cellular function and cell–matrix interactions. In chondrocyte monolayer cultures where HS levels are depleted by inclusion of heparanase in the culture medium, increased chondrocyte proliferative rates and GAG deposition occurs compared to control cultures [ 119 ].…”
Section: Heparanase Influences Chondrogenesis and Osteogenesismentioning
The aim of this study was to highlight the roles of perlecan in the regulation of the development of the rudiment developmental cartilages and growth plate cartilages, and also to show how perlecan maintains permanent articular cartilage homeostasis. Cartilage rudiments are transient developmental templates containing chondroprogenitor cells that undergo proliferation, matrix deposition, and hypertrophic differentiation. Growth plate cartilage also undergoes similar changes leading to endochondral bone formation, whereas permanent cartilage is maintained as an articular structure and does not undergo maturational changes. Pericellular and extracellular perlecan-HS chains interact with growth factors, morphogens, structural matrix glycoproteins, proteases, and inhibitors to promote matrix stabilization and cellular proliferation, ECM remodelling, and tissue expansion. Perlecan has mechanotransductive roles in cartilage that modulate chondrocyte responses in weight-bearing environments. Nuclear perlecan may modulate chromatin structure and transcription factor access to DNA and gene regulation. Snail-1, a mesenchymal marker and transcription factor, signals through FGFR-3 to promote chondrogenesis and maintain Acan and type II collagen levels in articular cartilage, but prevents further tissue expansion. Pre-hypertrophic growth plate chondrocytes also express high Snail-1 levels, leading to cessation of Acan and CoI2A1 synthesis and appearance of type X collagen. Perlecan differentially regulates FGF-2 and FGF-18 to maintain articular cartilage homeostasis, rudiment and growth plate cartilage growth, and maturational changes including mineralization, contributing to skeletal growth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.